DH
Insider
David Hung
PRESIDENT AND CEODavid Hung (PRESIDENT AND CEO) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Nuvation Bio Inc. (NUVB). Across 2 priced purchase filings, the average 21-session return was +37.6% from execution and +21.0% from disclosure (delay-adjusted; derived). The largest single filing was $895K of NUVB (500,000 sh × $1.79, as filed), executed Jun 16 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+37.6%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+21.0%
same 2 filings, from disclosure
Filings, ttm
2
2 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Jun 16 2025
Filed Jun 18 2025
Median ADV $43.2M across their filed names
Open performance→Volume by month
Buys $1.7M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
NUVB
Nuvation Bio Inc.
NUVB · 2 buys · 0 sells
2 filings
Recent filings
NUVBPURCHASE
Nuvation Bio Inc.
View filing →
$895K500,000 sh × $1.79
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET NUVBPURCHASE Nuvation Bio Inc. View filing → $821K
500,000 sh across 2 lots
Exec Apr 4 2025
Filed Apr 8 2025 · 5:30 PM ET